Can lisdexamfetamine dimesylate (Vyvanse) 60 mg be administered together with 5 mg of immediate‑release mixed amphetamine salts (Adderall IR) in the afternoon?

Can Vyvanse 60mg Be Combined with Adderall IR 5mg in the Afternoon?

Yes, combining Vyvanse 60mg in the morning with Adderall IR 5mg in the afternoon is a clinically appropriate and commonly used strategy for managing ADHD symptoms throughout the day, particularly when long-acting medication coverage wanes before the end of the day.

Rationale for Combination Therapy

This approach addresses a common clinical scenario where long-acting stimulants like Vyvanse provide insufficient coverage for late afternoon/evening activities. The practice is supported by established guidelines and pharmacological principles:

Guideline Support

The 2002 JAACAP practice parameter explicitly endorses this strategy, stating: "It has become common practice to combine short-acting MPH with MPH-SR20 to increase efficacy and duration of effect and allow more flexible dosing" 1. While this specific example references methylphenidate formulations, the same principle applies to amphetamine-based medications. The guideline notes this strategy is used "to smooth out the day-long response by eliminating breakthrough ADHD symptoms" 1.

Pharmacokinetic Considerations

The combination makes pharmacological sense based on Vyvanse's metabolism:

• Vyvanse reaches peak dextroamphetamine levels at approximately 3.5-4.4 hours post-dose 2
• The elimination half-life of dextroamphetamine is 10-11.3 hours in adults 2
• Therapeutic effects extend to approximately 14 hours post-dose in adults 3

By late afternoon (6-8 hours post-morning dose), Vyvanse's therapeutic effect may be declining, creating a coverage gap for evening activities like homework, driving, or work responsibilities.

Dosing Parameters

Your proposed regimen falls well within established safety limits:

• Maximum total daily amphetamine dose: 40mg (per PDR recommendations) 1
• Your total: 60mg Vyvanse = ~18mg dextroamphetamine equivalent + 5mg Adderall IR = ~23mg total amphetamine
• The guideline notes that "doses may go higher than the PDR-recommended upper limits on rare occasions" with expert consensus often limiting total daily amphetamine to 40mg 1

Clinical Implementation

Timing Strategy

• Administer Vyvanse 60mg in the morning (after breakfast or with/without food) 2
• Add Adderall IR 5mg in the afternoon (typically 4-6 hours after Vyvanse, avoiding late dosing that could cause insomnia)
• The FDA label specifically warns to "avoid afternoon doses because of the potential for insomnia" 2, so timing the IR dose appropriately (early-to-mid afternoon rather than late afternoon) is critical

Monitoring Requirements

Systematic assessment should include:

• Target ADHD symptoms throughout the day (morning, afternoon, evening coverage) 1
• Cardiovascular parameters: Blood pressure and pulse quarterly in adults 1
• Sleep quality and appetite (amphetamines cause greater sleep/appetite effects than methylphenidate due to longer half-lives) 1
• Signs of tolerance or dose escalation 1

Common Pitfalls to Avoid

1. Dosing too late in the day: The afternoon IR dose should be given early enough (typically by 2-3 PM) to avoid insomnia, given the 10-11 hour half-life 2

2. Inadequate assessment of need: Document that symptoms are not controlled with Vyvanse alone during late-day activities before adding the IR component 1

3. Overlooking cardiovascular monitoring: Adults require quarterly BP/pulse checks when on stimulants 1

4. Missing substance abuse risk factors: The 2011 AAP guideline emphasizes assessing for "symptoms of substance abuse" before treatment and monitoring for "signs of misuse or diversion" 4. Lisdexamfetamine has lower abuse potential than IR amphetamines 5, but adding IR formulations increases diversion risk

Special Considerations

Adolescents and Driving

The 2011 AAP guideline specifically notes: "Given the inherent risks of driving by adolescents with ADHD, special concern should be taken to provide medication coverage for symptom control while driving. Longer-acting or late-afternoon, short-acting medications might be helpful in this regard" 4. This directly supports your proposed strategy for adolescent patients.

Alternative to Consider

If insomnia becomes problematic, the timing or dose of the IR component can be adjusted downward (2.5mg instead of 5mg) or administered earlier in the afternoon.

The combination you describe is both evidence-based and clinically sound for managing full-day ADHD symptom coverage.